• Human Siglec-3/CD33 protein (Recombinant) (C-hFc&His) (STJP000934)
  • Human Siglec-3/CD33 protein (Recombinant) (C-hFc&His) (STJP000934)
  • Human Siglec-3/CD33 protein (Recombinant) (C-hFc&His) (STJP000934)
  • Human Siglec-3/CD33 protein (Recombinant) (C-hFc&His) (STJP000934)

Human Siglec-3/CD33 protein (Recombinant) (C-hFc&His) (STJP000934)

SKU:
STJP000934

Current Stock:
Host: HEK293 cells
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human Siglec-3/CD33-C-hFc&His protein was developed from hek293 cells and has a target region of C-hFc&His. For use in research applications.
Formulation: Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. Contact us for customized product form or formulation.
Immunoreactivity: Measured by its binding ability in a functional ELISA. Immobilized Human CD33 Protein at 1 Mu g/mL (100 Mu L/well) can bind CD33 Rabbit pAb with a linear range of 0.03-1.66 ng/mL.
Gene Symbol: CD33
Gene ID: 945
Uniprot ID: CD33_HUMAN
Immunogen: Recombinant Human Siglec-3/CD33 Protein is produced by HEK293 expression system. The target protein is expressed with sequence (Asp18-His259) of human CD33/Siglec-3 (Accession #NP_001763.3) fused with an Fc, 6Ă—His tag at the C-terminus.
Tissue Specificity Monocytic/myeloid lineage cells. In the brain, CD33 is mainly expressed on microglial cells.
Post Translational Modifications Glycosylated. Glycosylation at Asn-100 is critical for regulating ligand recognition. Phosphorylation of Tyr-340 is involved in binding to PTPN6 and PTPN11. Phosphorylation of Tyr-358 is involved in binding to PTPN6. LCK phosphorylates Tyr-340 efficiently and Tyr-358 to a lesser extent.
Function Sialic-acid-binding immunoglobulin-like lectin (Siglec) that plays a role in mediating cell-cell interactions and in maintaining immune cells in a resting state. Preferentially recognizes and binds alpha-2,3- and more avidly alpha-2,6-linked sialic acid-bearing glycans. Upon engagement of ligands such as C1q or syalylated glycoproteins, two immunoreceptor tyrosine-based inhibitory motifs (ITIMs) located in CD33 cytoplasmic tail are phosphorylated by Src-like kinases such as LCK. These phosphorylations provide docking sites for the recruitment and activation of protein-tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2. In turn, these phosphatases regulate downstream pathways through dephosphorylation of signaling molecules. One of the repressive effect of CD33 on monocyte activation requires phosphoinositide 3-kinase/PI3K.
Protein Name Myeloid Cell Surface Antigen Cd33
Sialic Acid-Binding Ig-Like Lectin 3
Siglec-3
Gp67
Cd Antigen Cd33
Database Links Reactome: R-HSA-198933
Reactome: R-HSA-6798695
Cellular Localisation Isoform Cd33m: Cell Membrane
Single-Pass Type I Membrane Protein
Isoform Cd33m: Peroxisome
Cd33m Isoform Does Not Localize To Cell Surfaces But Instead Accumulates In Peroxisomes
Alternative Protein Names Myeloid Cell Surface Antigen Cd33 protein
Sialic Acid-Binding Ig-Like Lectin 3 protein
Siglec-3 protein
Gp67 protein
Cd Antigen Cd33 protein
CD33 protein
SIGLEC3 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance